Smoking Cessation - Zenodo

Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes

Importance Abstract Importance The evidence of successful smoking cessation interventions in diabetic patients is scant. A randomized clinical trial of the smoking cessation drug varenicline is warranted due to the unique behavioral and metabolic characteristics of smokers with type 2 diabetes. With the intention of quitting smoking, we want to determine the effectiveness and safety of vaping in patients with type 2 diabetes. Patients in both treatment groups also received smoking cessation education. P Conclusions and Relevance The CAR was significantly higher than placebo group 24. 0% vs. 6. 0%; odds ratio [OR], 4. 95; 9. 70; P P]. Statistical analysis The CAR was also higher than placebo group 24-70; 9. 90; 9. 70; 92 percent; 0. 80] 9. 70; P P: Conclusions and Relevance [OR], 9. 65; 9. 60 vs. 10. 70; P P. Varenicline should be used in diabetes education programs to encourage patients with type 2 diabetes from smoking regularly.

Source link: https://zenodo.org/record/6676410

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions